.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Alchemy (Ieso)’s mix tilted toward Vapor Pens at 45.10% share with a 23.89% month-over-month lift, while the same category was down 61.92% year over year; Concentrates held 30.76% share with a 12.97% month-over-month decline and a 58.14% year-over-year drop. Edible accounted for 19.26% share with a 16.09% month-over-month decline but a near-flat 0.11% year-over-year change, and Topical reached 4.45% share with a 33.39% month-over-month gain and a 0.26% year-over-year dip; Flower remained marginal at 0.43% share, spiking 97.92% year over year but falling 89.50% month over month. With average price down 28.37% year over year to $23.87 and overall brand sales down 53.68% year over year, the pattern implies reliance on a rebounding Vapor Pens month-over-month engine that has not offset deep year-over-year erosion concentrated in inhalables.
The category shifts position Alchemy (Ieso) as a value-leaning inhalables player anchored in Illinois Vapor Pens, where a rank of 40 indicates mid-pack visibility even as month-over-month momentum improves by 23.89%. The relatively stable Edible year-over-year trend at -0.11% alongside a 16.09% month-over-month pullback, paired with Topical’s 33.39% month-over-month upswing on just 4.45% share, suggests diversification headroom beyond inhalables; however, the 58.14% year-over-year decline in Concentrates and 61.92% in Vapor Pens signal that price-led repositioning has not yet restored category share at scale. Net, the configuration implies that short-term recovery will hinge on sustaining Vapor Pens mix above 45% while converting Topical’s month-over-month gains into repeatable share and stabilizing Edible to counter the inhalables year-over-year drag.
Competitive Landscape
Alchemy (Ieso) sits at rank #40 in May 2026, down 22 positions year over year from #18, yet up 5 ranks versus February 2026 when it was #45, indicating a recent quarter-over-quarter lift amid a longer YoY slide. At the top end, &Shine held #1 with a 1-to-1 YoY rank repeat while posting a 2.48% sales decline, and Select is #2 after climbing from #3 as its sales fell 5.37%, suggesting that Alchemy (Ieso)’s drop was not solely due to leaders expanding. Meanwhile, Joos holds #3 from #2 despite a 39.65% sales contraction, and RYTHM advanced to #4 from #5 with an 11.40% sales decline, implying that competitive share shuffled even as category revenue softened. The pattern—YoY rank deterioration to #40 alongside a 5-rank rebound since February 2026 and a prior peak of #15 in February 2025—implies Alchemy (Ieso) is stabilizing off its lows but remains structurally displaced from its former tier, requiring either product mix or distribution changes to reclaim mid-teens positioning.
Notable Products
Sleep Potion - CBN/THC 5:1 Black Raspberry Gummies 20-Pack (500mg CBN, 100mg THC) posted the steepest decline in May 2026 with a -38.9% MoM drop and fell behind the top two ranks, implying demand is pivoting away from high-CBN sleep formats. In contrast, CBD/THC 20:1 Orange Pineapple Healing Gummies 20-pack (2000mg CBD,100mg THC) grew +25.1% MoM while holding rank 1, and CBD/CBG/THC 3:2:1 Cranberry Lime Gummies 20-Pack (300mg CBD, 200mg CBG, 100mg THC) slid -21.8% at rank 2, creating a spread where wellness-skewed CBD leadership coexists with declines in adjacent minor-cannabinoid blends; four of the top ten are Edible SKUs, concentrating share in functional gummies. With Vapor Pens like Outer Space Distillate Cartridge (1g) entering at rank 4 alongside Banana Munson and Cherry Pie at ranks 9 and 10 and a single concentrate Stella Blue Cured Budder (1g) at rank 8, the mix signals a shift toward a two-pillar portfolio where CBD-led gummies anchor volume while inhalables re-enter to diversify beyond gummies; this implies Alchemy (Ieso) is reallocating emphasis from sleep-specific CBN formats toward broad wellness gummies and ready-to-scale pen SKUs.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
